Research and Development

Ablynx has achieved a pre-clinical proof-of-concept with a nanobody construct as part of its immuno-oncology collaboration with Merck – triggering …

Crescendo Biologics has announced the appointment of Dr Peter Pack as chief executive, who will oversee the company’s new drug …

Merck and biopharma firm Incyte are to expand their clinical collaboration to include a Phase III study evaluating the combination …

Johnson & Johnson has begun a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen …

Takeda is teaming up with researchers at University College London (UCL) to identify and validate novel target genes for the …

Vedanta Biosciences, a PureTech Health company developing a new class of therapies designed to modulate the human microbiome, has announced …

Merck Group has rebranded to “reflect its transformation into a science and technology company”, and restructured its business to create …

Teva has partnered with the IBM Watson Health Cloud to create a global technology platform to aid its R&D efforts …

This report provides a comprehensive view of the clinical, R&D, commercial and competitive landscape of gene therapy, and assesses key …

Shire has announced that the United States Food and Drug Administration (FDA) has granted fast track designation for the investigation …

MedImmune has joined the Human Vaccines Project, which aims to accelerate the research and development of vaccines and immunotherapies for …

Novartis is to invest an extra $15 million into Israeli stem cell therapy developer Gamida Cell, adding an additional 2.5% …

Merck KGaA has announced the promotion of its deputy chief executive, Stefan Oschmann, to the role of chief executive, starting …

NICE is introducing a new service, the Office for Market Access (OMA), to work with industry to speed up NHS …

Boston-based biopharmaceutical company Berg recently announced it joined an industry collaboration with Genomics England, set up by UK Prime Minister …